Ascendis Pharma A/S Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Ascendis Pharma A/S (ASND) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of EUR 291.76 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2026-02-11
- 2025-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 291.76M EUR.
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 164.48M EUR.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 16.26M EUR.
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 19.96M EUR.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2025-12-31 | 291.76M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 164.48M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 16.26M EUR 20-F · filed 2026-02-11 |
| 2022-12-31 | 19.96M EUR 20-F · filed 2025-02-12 |
| 2021-12-31 | 12.86M EUR 20-F · filed 2024-02-07 |